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Background: Loss of function mutations in the genes encoding the pancreatic β-cell
ATP-sensitive potassium (KATP) channel are identiﬁed in approximately 80% of patients
with diazoxide unresponsive hyperinsulinemic hypoglycemia (HH). For a small number of
patients HH can occur as part of a multisystem disease such as Beckwith–Wiedemann
syndrome (BWS). In approximately 20% of patients, BWS results from chromosome 11
paternal uniparental disomy (UPD), which causes dysregulation of imprinted growth regula-
tion genes at 11p15.5.There is a considerable range in the clinical features and phenotypic
severity associated with BWS which is likely to be due to somatic mosaicism. The cause
of HH in these patients is not known. Research Design and Methods: We undertook
microsatellite analysis of 12markers spanning chromosome11p in two patientswith severe
HH and diffuse disease requiring a pancreatectomy. In both patients mutations in the KATP
channel genes had not been identiﬁed. Results: We identiﬁed segmental paternal UPD
in DNA extracted from pancreatic tissue in both patients. UPD was not observed in DNA
extracted from the patient’s leukocytes or buccal samples. In both cases the UPD encom-
passed the differentially methylated region at chromosome 11p15.5. Despite this neither
patient had any further features of BWS. Conclusion: Paternal UPD of the chromosome
11p15.5 differentially methylated region limited to the pancreatic tissue may represent a
novel cause of isolated diazoxide unresponsive HH. Loss of heterozygosity studies should
therefore be considered in all patients with severe HH who have undergone pancreatic
surgery when KATP channel mutation(s) have not been identiﬁed.
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INTRODUCTION
Hyperinsulinemichypoglycemia (HH) is aheterogeneousdisorder
characterized by dysregulated insulin secretion. A range in clinical
severity is observed with some patients presenting with mild tran-
sient hypoglycemia whilst others have persistent HH that requires
medical management. In the most severe cases where euglycemia
is not achieved despite intensive therapy, pancreatic surgery may
be required.
For approximately 80% of patients who require pancreatic
surgery, HH is due to inactivating mutation(s) in genes encoding
the SUR1 (ABCC8) and Kir6.2 (KCNJ11) subunits of the pan-
creatic β-cell ATP-sensitive potassium (KATP) channel (Thomas
et al., 1995; Thomas et al., 1996; Bellanne-Chantelot et al., 2010).
A genetic diagnosis is clinically important for these patients as
the mode of inheritance provides information on the histo-
logical subtype. Typically, diffuse disease affects all the β-cells
and is most commonly due to recessive mutations in KCNJ11
or ABCC8. Patients with diazoxide unresponsive diffuse disease
often require a near total pancreatectomy. In contrast, in focal
disease, the affected area is localized to a single region of the
pancreas.
The genetic etiology of focal HH is distinct from that of the
diffuse form and involves a paternally inherited ABCC8/KCNJ11
mutation and paternal uniparental isodisomy (UPD) within the
focal lesion (de Lonlay et al., 1997; Damaj et al., 2008). The
UPD unmasks the recessive mutation and causes a dysregula-
tion of imprinted genes at chromosome 11p15.5. For patients
with a paternally inherited mutation a 18FDOPA-PET CT scan is
required to conﬁrm and localize the focal lesion following which
the patient may undergo a curative lesionectomy (de Lonlay et al.,
1997; Otonkoski et al., 2006).
Medically unresponsive HH has also been reported in patients
with Beckwith–Wiedemann syndrome (BWS; MIM #130650;
Debaun et al., 2000; Munns and Batch, 2001). In these patients
BWS can result from multiple genetic mechanisms, including
mosaic paternal UPD, which causes a dysregulation of imprinted
genes at chromosome 11p15.5 (reviewed inWeksberg et al., 2005).
A range of clinical features and severity of phenotype is observed
in BWS with typical features including macrosomia, macroglos-
sia, abdominal wall defects, hemihyperplasia, embryonal tumors,
adrenocortical cytomegaly, ear anomalies, visceromegaly, renal
abnormalities, cleft palate, and neonatal HH. Hypoglycemia
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occurs in approximately 50% of cases and is highly variable in
terms of duration and clinical severity. In some patients HH may
be transient, resolving within the ﬁrst few days of life, whilst
in approximately 5% of children the HH is persistent and may
require pancreatic surgery (Debaun et al., 2000;Munns and Batch,
2001). Although the underlying mechanism leading to HH in
these patients is unclear, the variability in clinical phenotype has
been attributed to the level of mosaicism for the somatic mutation
within the various affected tissues (Smith et al., 2007).
We report two cases with severe, medically unresponsive HH
anddiffuse histological disease inwhompaternalUPDof the chro-
mosome 11p15.5 imprinted region was found within pancreatic
tissue. Neither patient has any other feature associated with BWS.
MATERIALS AND METHODS
CLINICAL STUDIES
The study was conducted in accordance with the Declaration
of Helsinki 2000 and informed consent was obtained from the
parents on behalf of their children.
MOLECULAR GENETICS
Genomic DNA was extracted from peripheral leukocytes of the
patients and parents and from resected pancreatic tissue and
buccal cells (when available) from the patients using standard
procedures. The coding regions, intron exon/boundaries, and the
minimal promoter regions of the ABCC8 and KCNJ11 genes
were ampliﬁed and sequenced as previously described (Flana-
gan et al., 2007; primers for minimal promoter regions available
on request). Sequences were compared to published sequences
(NM_000525.3 andNM_000352.2) usingMutation Surveyor soft-
ware (SoftGenetics, State College, PA, USA). When no coding
mutation was identiﬁed dosage analysis of the ABCC8 gene was
undertaken using mulitplex ligation-dependent probe ampliﬁca-
tion (MLPA) as per the manufacturer’s instructions (Kit P117,
MRCHolland,Amsterdam,Netherlands). Products were analyzed
using GeneMarker software v1.85 (SoftGenetics, State College, PA,
USA).
Loss of heterozygosity of chromosome 11 was investigated by
the analysis of 12 microsatellite makers on chromosome 11p.
Details of the microsatellite markers are provided in Figure 1.
The 12markers were ampliﬁed by PCR using DNA extracted from
the patient and parental leukocytes and DNA from the patients
resectedpancreatic tissue andwhenavailable buccal cells (details of
primers available on request). The ﬂuorescently tagged PCR prod-
ucts were run on an ABI 3100 (Applied Biosystems, Warrington,
UK) and the allele peak heights were compared using GeneMarker
software v1.85 (SoftGenetics, State College, PA, USA).
RESULTS
CASE REPORTS
Proband 1
The male patient was born at 40weeks gestation with a birth
weight of 3900 g to unaffected parents. He was noted to be hypo-
glycemic on the ﬁrst day of life (blood glucose of 1.1mmol/l) with
biochemical evidence of HH. An intravenous glucose infusion of
24mg/kg/min was required to maintain normoglycemia. He was
unresponsive to diazoxide and hence was stabilized on a subcu-
taneous infusion of octreotide while awaiting surgery. Pancreatic
biopsy performed in the 7th week of life revealed enlarged clus-
ters of islet tissue without nuclear enlargement or hyperchromasia
and arranged in ribbon-like pattern. Very little exocrine tissue was
apparent. He underwent a near total pancreatectomy at 9weeks
of age following which he achieved normoglycemia. The resected
pancreas showed the samehistological changes as the biopsy. These
appearances are those seen in focalHHbut involved the entire pan-
creas. Currently, at 6 years of age, he remains normoglycemic and
is neurodevelopmentally appropriate for his age.
Proband 2
Themale patient was born at term with a birth weight of 3870 g to
healthy parents. Symptomatic hypoglycemiawasnoted at 7 hof life
FIGURE 1 | Results of microsatellite analysis of markers on
chromosome 11p amplified from leukocyte DNA of the probands
and their parents and from the pancreatic DNA from the
probands. Red text represents markers which are informative for
paternal UPD, green text represents markers which show no
evidence of UPD, and blue texts represents markers which are
uninformative. The distance between the marker and the telomere at
11p is provided.
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andHHwas conﬁrmed biochemically. He required an intravenous
glucose infusion of 25mg/kg/min to maintain normoglycemia
and did not respond to a trial of medical treatment (diazoxide,
octreotide, and nifedipine). At 8weeks of age, he underwent 50%
resection of his pancreas, followed by a near total pancreatec-
tomy as hypoglycemia persisted post-operatively. Histology of the
resected pancreas revealed excess of enlarged islets with endocrine
cells forming ribbons. The amount of exocrine tissue was greatly
reduced. These histological appearances are seen in focal HH but
the pathology involved the entire pancreas.
Following a near total pancreatectomy, he wasmanaged on oral
diazoxide and regular gastrostomy feeds (continuous overnight
and daytime bolus feeds) tomaintain normoglycemia. The patient
is currently 6.8 years of age and is on minimal doses of diazox-
ide (6mg/kg/day) and daytime gastrostomy feeds to maintain
normoglycemia along with pancreatic enzyme supplementation
for exocrine insufﬁciency. There are no neurodevelopmental
concerns.
GENETICS
Sequencing analysis of theKCNJ11 andABCC8 genes did not iden-
tify a mutation in leukocyte DNA from either patient and MLPA
analysis of the ABCC8 gene conﬁrmed normal gene dosage in
leukocyte and pancreatic tissue from both cases.
In proband 1 microsatellite analysis of four markers span-
ning the chromosome 11p15.5 region (2.23Mb) demonstrated a
reduced peak height for the maternal allele in the pancreatic tissue
when compared to the leukocyte and buccal cell DNA (Figures 1
and 2, results from buccal cells not shown). One marker was
uninformative and four markers were heterozygous in all three
FIGURE 2 | A region of chromosome 11 has been expanded to
demonstrate the area of UPD in relation to the location of the imprinted
locus at 11p15.5 and theABCC8 and KCNJ11 genes. IC denotes the
imprinted control regions 1 and 2. Red text represents markers which are
informative for paternal UPD, green text represents markers which show no
evidence of UPD, and blue texts represents uninformative markers. Directly
below are electropherograms that demonstrate the results of microsatellite
analysis for one of the markers (D11S1318 and D11S1397) which are
informative for UPD in pancreatic tissue for each of the probands. The x -axis
indicates the size of the product (base pairs) and the y -axis denotes the
product quantity (arbitrary units). In each example mosaic paternal UPD is
illustrated by a larger peak for the paternal allele compared to the maternal.
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samples. These results conﬁrmed segmental loss of the short arm
of the maternal chromosome 11 (maximum size 5.89Mb) within
the pancreatic tissue but not within the buccal or leukocyte DNA
(Figure 2).
In proband 2, six markers spanning 17.68Mb on chromo-
some 11p15.5–11p15.1 demonstrated a reduced peak height for
the maternal allele in the pancreatic tissue when compared to
the leukocyte DNA (Figures 1 and 2). Three markers were unin-
formative and four markers were heterozygous in the leukocyte
and pancreatic samples deﬁning the maximum region of loss of
heterozygosity as 35.92Mb.
DISCUSSION
Microsatellite analysis revealed a loss of the maternal chromo-
some 11p15.5 allele in DNA extracted from pancreatic tissue in
two patients with diazoxide unresponsive HH and diffuse pancre-
atic disease. In one patient the region was limited to chromosome
11p15.5 whilst in the second patient the loss of heterozygosity
extended over ABCC8 and KCNJ11. In this patient sequencing of
the coding regions, intron/exon boundaries, andminimal promot-
ers of the KATP channel genes and ABCC8 gene dosage studies did
not identify amutation, although this does not exclude amutation
in the non-coding regions of these genes.
In both patients the maximum shared region of maternal
loss of heterozygosity spanned 5.89Mb which encompassed the
genes IGF2, H19, KCNQ1, KCNQ10T1, CDKN1C, PHLD1, and
SLC22A18, and the imprinted control regions which have been
implicated in BWS and growth regulation (Figure 2). In proband
2, where the loss of heterozygosity extended over the KATP chan-
nel genes, ABCC8 gene dosage studies conﬁrmed normal diploid
copy number within the pancreatic tissue which suggests that
the loss of heterozygosity is likely to be due to mosaic segmental
paternal UPD.
Paternal UPD of chromosome 11p15.5 accounts for approxi-
mately 20% of BWS cases and in the vast majority of cases patients
exhibit somatic mosaicism (Henry et al., 1991). The presence
of mosaicism implies that in these patients UPD arises post-
zygotically as a result of somatic recombination and therefore the
tissues that will be affected will depend on the timing at which
this event occurs during embryogenesis. As severe HH requir-
ing pancreatectomy has been reported in patients with BWS it
seems likely that paternal UPD over the BWS locus within the
pancreatic tissue is responsible for the severe HH observed in our
patients (Debaun et al., 2000;Munns and Batch, 2001; Smith et al.,
2007). In addition, the histopathology in these patients is similar
to that reported in BWS (Hussain et al., 2005). Further studies are
required to elucidate the mechanism of HH in these patients.
Despite extensive clinical examination no further features of
BWS were detected in either patient which is likely to reﬂect the
absence of UPD in other tissues. This hypothesis is supported
by previous reports which identiﬁed chromosome 11p15 UPD in
patients with isolated hemihyperplasia with or without embryonal
tumors (Grundy et al., 1991; Weksberg et al., 2005). It has been
suggested that these patients reﬂect the milder end of the BWS
spectrum (Weksberg et al., 2005). Whilst it would be interesting
to have investigated the presence/level of UPD in other “unaf-
fected” tissues in these two cases the only sample in addition to
leukocyte and pancreatic DNA that was available for testing was
buccal cells from one patient. Microsatellite analysis using DNA
extracted from buccal cells demonstrated heterozygosity for all
markers tested which is in keeping with the absence of, or low
level UPD.
Currently for around 20% of patients with severe HH which
requires a pancreatectomy sequencing and dosage analysis of the
ABCC8 andKCNJ11 genes does not identify amutation (Bellanne-
Chantelot et al., 2010). Our ﬁnding that mosaic paternal UPD of
chromosome 11p15.5, limited to pancreatic tissue, can cause HH
without features of BWS suggest that loss of heterozygosity stud-
ies should be undertaken when pancreatic tissue is available. This
genetic diagnosis is clinically important as it provides information
regarding recurrence risk and also, in the absence of other tissue
available for testing, these patients should be monitored closely
as they may be at high risk of embryonal tumors (Henry et al.,
1991).
In conclusion, we have demonstrated paternal UPD of the
chromosome 11p15.5 differentially methylated region within the
pancreatic tissue in two patients with isolated HH. The absence of
UPD in other tissues tested is in keeping with the lack of features
associatedwith BWS. Thismechanismmay represent a novel cause
of isolated diazoxide unresponsive HH and should be considered
in all patients without a KATP channel mutation where pancreatic
tissue is available.
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